These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18516820)

  • 21. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-tuberculosis drug resistance in Dohuk, Iraq.
    Merza MA; Farnia P; Masjedi MR; Ridell M
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1213-4. PubMed ID: 20819274
    [No Abstract]   [Full Text] [Related]  

  • 27. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 28. Tuberculosis diagnosis--time for a game change.
    Small PM; Pai M
    N Engl J Med; 2010 Sep; 363(11):1070-1. PubMed ID: 20825320
    [No Abstract]   [Full Text] [Related]  

  • 29. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 31. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment on "Thwaites et al., 2005, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis" J Infect Dis. 2005 Dec 15;192(12):2134-41.
    Dhasmana DJ; Davidson RN
    J Infect; 2007 Feb; 54(2):205; author reply 206. PubMed ID: 16887190
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century.
    Heifets LB; Cangelosi GA
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):564-81. PubMed ID: 10423219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 37. Standardisation of sensitivity tests.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):69-70. PubMed ID: 9562114
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced multifocal tuberculous spondylitis without disk involvement and with multidrug-resistant bacilli.
    Neher A; Kopp W; Berna G; Frank J; Kohlhäufl M
    Clin Infect Dis; 2007 Oct; 45(8):e109-12. PubMed ID: 17879905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.
    Mitchell SL; Seoudi N; Hutchison DC; Drobniewski FA
    Thorax; 2011 Jul; 66(7):630-1. PubMed ID: 20880876
    [No Abstract]   [Full Text] [Related]  

  • 40. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.